EverFlex Post Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

Also called NCT01680835

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01680835
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01680835. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01-14 (actual); primary completion 2018-10-23 (actual). Results posted on 2019-12-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EverFlex Post Approval Study
Acronym
DURABILITY PAS
Condition
Peripheral Arterial Disease
Condition
Lower Extremity Arterial Disease
Intervention (Device)
EverFlex™ Self-Expanding Peripheral Stent System
Lead sponsor
Medtronic Endovascular (class: industry)

Record details

Record id
cardio:ct-nct01680835
Content hash
83e0d9e81d62592713ed200a685d47af6e650d63c40893eeecbf1bded1af0099